The global fusion biopsy market size accounted for USD 802.72 million in 2025 and is predicted to hit around USD 1,690.87 million by 2034, representing a CAGR of 8.63% between 2025 and 2034. The North America fusion biopsy market size was calculated at USD 302.97 million in 2024 and is expected to grow at notable a CAGR of 8.76% during the forecast year. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Fusion Biopsy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Fusion Biopsy Market, by Biopsy Route
8.1.1. Transrectal
8.1.1.1. Market Revenue and Forecast
8.1.2. Transperineal
8.1.2.1. Market Revenue and Forecast
9.1. Fusion Biopsy Market, by End Use
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast
9.1.2. Diagnostic Centers
9.1.2.1. Market Revenue and Forecast
9.1.3. Ambulatory Care Centers
9.1.3.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Biopsy Route
10.1.2. Market Revenue and Forecast, by End Use
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Biopsy Route
10.1.3.2. Market Revenue and Forecast, by End Use
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Biopsy Route
10.1.4.2. Market Revenue and Forecast, by End Use
10.2. Europe
10.2.1. Market Revenue and Forecast, by Biopsy Route
10.2.2. Market Revenue and Forecast, by End Use
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Biopsy Route
10.2.3.2. Market Revenue and Forecast, by End Use
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Biopsy Route
10.2.4.2. Market Revenue and Forecast, by End Use
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Biopsy Route
10.2.5.2. Market Revenue and Forecast, by End Use
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Biopsy Route
10.2.6.2. Market Revenue and Forecast, by End Use
10.3. APAC
10.3.1. Market Revenue and Forecast, by Biopsy Route
10.3.2. Market Revenue and Forecast, by End Use
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Biopsy Route
10.3.3.2. Market Revenue and Forecast, by End Use
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Biopsy Route
10.3.4.2. Market Revenue and Forecast, by End Use
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Biopsy Route
10.3.5.2. Market Revenue and Forecast, by End Use
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Biopsy Route
10.3.6.2. Market Revenue and Forecast, by End Use
10.4. MEA
10.4.1. Market Revenue and Forecast, by Biopsy Route
10.4.2. Market Revenue and Forecast, by End Use
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Biopsy Route
10.4.3.2. Market Revenue and Forecast, by End Use
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Biopsy Route
10.4.4.2. Market Revenue and Forecast, by End Use
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Biopsy Route
10.4.5.2. Market Revenue and Forecast, by End Use
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Biopsy Route
10.4.6.2. Market Revenue and Forecast, by End Use
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Biopsy Route
10.5.2. Market Revenue and Forecast, by End Use
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Biopsy Route
10.5.3.2. Market Revenue and Forecast, by End Use
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Biopsy Route
10.5.4.2. Market Revenue and Forecast, by End Use
11.1. Eigen
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Koninklijke Philips N.V.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hitachi Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. MedCom
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. ESAOTE SPA
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. KOELIS
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Focal Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. BK Medical Holding Company, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Exact Imaging
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Biobot Surgical Pte Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description